Don’t miss this interesting webinar with Dominic Clarke, Global Head of Cell Therapy, HemaCare and David Smith, Head of Innovation and Engineering, Hitachi Chemical Advanced Therapeutics Solutions, now available on demand for free! Simply fill out the form to learn:
- How inherent challenges with current preservation methodologies impact cell therapy manufacturing processes and product quality.
- What approaches you can harness to extend the stability of your starting material.
- How data from initial studies is demonstrating the potential to extend the stability window.
- How this can help alleviate logistics constraints, preserve starting material quality and reduce downstream processing variability.